Sign in
4

Changes in Ownership

Vor Biopharma Inc. Filed Acc 0001209191-22-048724

Chief Financial Officer acquired 86,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Jorgensen Nathan D. Chief Financial Officer 2022-09-01 Grant or award +86,000 115,269 D
Derivatives
Jorgensen Nathan D. Chief Financial Officer 2022-09-01 Grant or award · Employee Stock Option (right to buy) +86,000 86,000 D
Loading xslF345X03/doc4.xml…